PMC:7396557 / 12613-13107
Annnotations
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T77 | 9-17 | SP_7 | denotes | COVID-19 |
| T78 | 128-137 | UBERON:0000916 | denotes | abdominal |
| T79 | 200-215 | CHEBI:52217;CHEBI:52217 | denotes | Pharmacological |
| T80 | 241-256 | CHEBI:52217;CHEBI:52217 | denotes | pharmacological |
| T81 | 325-331 | UBERON:0002405 | denotes | immune |
| T82 | 332-342 | GO:0065007 | denotes | regulatory |
| T83 | 364-380 | UBERON:0005409 | denotes | gastrointestinal |
| T84 | 439-454 | CHEBI:52217;CHEBI:52217 | denotes | Pharmacological |
| T32885 | 9-17 | SP_7 | denotes | COVID-19 |
| T32005 | 128-137 | UBERON:0000916 | denotes | abdominal |
| T28814 | 200-215 | CHEBI:52217;CHEBI:52217 | denotes | Pharmacological |
| T64795 | 241-256 | CHEBI:52217;CHEBI:52217 | denotes | pharmacological |
| T11967 | 325-331 | UBERON:0002405 | denotes | immune |
| T30040 | 332-342 | GO:0065007 | denotes | regulatory |
| T74088 | 364-380 | UBERON:0005409 | denotes | gastrointestinal |
| T76767 | 439-454 | CHEBI:52217;CHEBI:52217 | denotes | Pharmacological |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T64 | 9-17 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T65 | 177-185 | Disease | denotes | diarrhea | http://purl.obolibrary.org/obo/MONDO_0001673 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T64021 | 287-290 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T56763 | 343-353 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activities |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T54 | 291-300 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T118 | 62-186 | Sentence | denotes | The indicative symptoms include weakness, headache and dizziness, abdominal fullness and distention, vomiting, and diarrhea. |
| T119 | 188-233 | Sentence | denotes | Progress of Pharmacological Research on HXZQC |
| T120 | 234-429 | Sentence | denotes | Modern pharmacological studies have found that HXZQC has antiviral, anti-inflammatory, and immune regulatory activities, improves gastrointestinal discomfort and other properties (see Table 3 ). |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T18 | 104-112 | Phenotype | denotes | headache | http://purl.obolibrary.org/obo/HP_0002315 |
| T19 | 117-126 | Phenotype | denotes | dizziness | http://purl.obolibrary.org/obo/HP_0002321 |
| T20 | 163-171 | Phenotype | denotes | vomiting | http://purl.obolibrary.org/obo/HP_0002013 |
| T21 | 177-185 | Phenotype | denotes | diarrhea | http://purl.obolibrary.org/obo/HP_0002014 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 188 | 9-17 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 189 | 94-102 | Disease | denotes | weakness | MESH:D018908 |
| 190 | 104-112 | Disease | denotes | headache | MESH:D006261 |
| 191 | 117-126 | Disease | denotes | dizziness | MESH:D004244 |
| 192 | 163-171 | Disease | denotes | vomiting | MESH:D014839 |
| 193 | 177-185 | Disease | denotes | diarrhea | MESH:D003967 |